Vildagliptin ameliorates biochemical, metabolic and fatty changes associated with non alcoholic fatty liver disease

OBJECTIVE: To determine the effect of Vildagliptin in non-alcoholic, fatty liver disease patients with dyslipidemia. METHODS: A randomized placebo controlled trial was conducted at outpatient clinic of Medical Unit-I of Sheikh Zayed Medical College/Hospital, Rahim Yar Khan, in which fifty eight pati...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Pak J Med Sci
Main Authors: Hussain, Mazhar, Majeed Babar, Muhammad Zafar, Hussain, Muhammad Shahbaz, Akhtar, Lubna
Format: Artigo
Jezik:Inglês
Izdano: Professional Medical Publications 2016
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5216289/
https://ncbi.nlm.nih.gov/pubmed/28083033
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12669/pjms.326.11133
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki